Psoriatic arthritis in a military aviator.
Psoriatic arthritis is a chronic spondyloarthropathy whose pathogenesis is unknown. We present a case of a naval flight officer who presented with chronic psoriatic arthritis, which ultimately became well controlled with etanercept treatment. The naval flight officer was granted military aeromedical waivers for psoriatic arthritis, cutaneous psoriasis, and chronic medication use. We also review the medical literature on psoriatic arthritis disease and etanercept and discuss their aeromedical implications in military aviation.
Sulit
Daryl J
DJ
Marine Corps Air Station, Naval Branch Health Clinic, Beaufort, SC 29904-5020, USA. djsulit@beaufort.med.navy.mil
Clarke
Jonathan E
JE
D000328:Adult; D000337:Aerospace Medicine; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy*; D001359:Aviation; D002908:Chronic Disease; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D008297:Male; D008887:Military Medicine; D008889:Military Personnel; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept